Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis
Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska, Tadeusz Łapiński, Aleksandra Berkan-Kawińska, Beata Bolewska, Magdalena Tudrujek-Zdunek, Dorota Kozielewicz, Marta Rorat, Piotr Leszczyński, Krzysztof Kłos, Justyna Kowalska, Paweł Pabjan, Anna Piekarska, Iwona Mozer-Lisewska, Krzysztof Tomasiewicz, Małgorzata Pawłowska, Krzysztof Simon, Joanna Polańska, Dorota Zarębska-Michaluk
doi: https://doi.org/10.1101/2021.01.28.21249932
Robert Flisiak
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland
Jerzy Jaroszewicz
2Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland
Magdalena Rogalska
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland
Tadeusz Łapiński
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland
Aleksandra Berkan-Kawińska
3Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź, Poland
Beata Bolewska
4Department of Infectious Diseases, University of Medical Sciences, Poznań, Poland
Magdalena Tudrujek-Zdunek
5Department of Infectious Diseases and Hepatology, Medical University of Lublin, Lublin, Poland
Dorota Kozielewicz
6Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Poland
Marta Rorat
7Department of Forensic Medicine, Wrocław Medical University, Wrocław, Poland
8First Infectious Diseases Ward, Gromkowski Regional Specialist Hospital in Wrocław, Wrocław, Poland
Piotr Leszczyński
9Department of Rheumatology, Rehabilitation and Internal Medicine, Poznan University of Medical Sciences
10Department of Rheumatology and Osteoporosis, Szpital im. J. Strusia w Poznaniu
Krzysztof Kłos
11Department of Infectious Diseases and Allergology, Military Institute of Medicine, Warsaw, Poland
Justyna Kowalska
12Department of Adults’ Infectious Diseases, Medical University of Warsaw, Warsaw, Poland
Paweł Pabjan
13Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
Anna Piekarska
3Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź, Poland
Iwona Mozer-Lisewska
4Department of Infectious Diseases, University of Medical Sciences, Poznań, Poland
Krzysztof Tomasiewicz
5Department of Infectious Diseases and Hepatology, Medical University of Lublin, Lublin, Poland
Małgorzata Pawłowska
6Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Poland
Krzysztof Simon
14Department of Infectious Diseases and Hepatology, Wrocław Medical University, Wrocław, Poland
Joanna Polańska
15Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland
Dorota Zarębska-Michaluk
13Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
Article usage
Posted February 01, 2021.
Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis
Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska, Tadeusz Łapiński, Aleksandra Berkan-Kawińska, Beata Bolewska, Magdalena Tudrujek-Zdunek, Dorota Kozielewicz, Marta Rorat, Piotr Leszczyński, Krzysztof Kłos, Justyna Kowalska, Paweł Pabjan, Anna Piekarska, Iwona Mozer-Lisewska, Krzysztof Tomasiewicz, Małgorzata Pawłowska, Krzysztof Simon, Joanna Polańska, Dorota Zarębska-Michaluk
medRxiv 2021.01.28.21249932; doi: https://doi.org/10.1101/2021.01.28.21249932
Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis
Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska, Tadeusz Łapiński, Aleksandra Berkan-Kawińska, Beata Bolewska, Magdalena Tudrujek-Zdunek, Dorota Kozielewicz, Marta Rorat, Piotr Leszczyński, Krzysztof Kłos, Justyna Kowalska, Paweł Pabjan, Anna Piekarska, Iwona Mozer-Lisewska, Krzysztof Tomasiewicz, Małgorzata Pawłowska, Krzysztof Simon, Joanna Polańska, Dorota Zarębska-Michaluk
medRxiv 2021.01.28.21249932; doi: https://doi.org/10.1101/2021.01.28.21249932
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (195)
- Cardiovascular Medicine (2874)
- Dermatology (244)
- Emergency Medicine (432)
- Epidemiology (12597)
- Forensic Medicine (10)
- Gastroenterology (809)
- Genetic and Genomic Medicine (4470)
- Geriatric Medicine (405)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1056)
- Hematology (378)
- HIV/AIDS (905)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4226)
- Nursing (226)
- Nutrition (619)
- Oncology (2215)
- Ophthalmology (629)
- Orthopedics (255)
- Otolaryngology (321)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1181)
- Primary Care Research (485)
- Public and Global Health (6810)
- Radiology and Imaging (1499)
- Respiratory Medicine (904)
- Rheumatology (430)
- Sports Medicine (372)
- Surgery (474)
- Toxicology (59)
- Transplantation (204)
- Urology (175)